Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pAAV-Hb9-LMO3 (sbGLuc-VChR1-EYFP)
(Plasmid #114103)


Item Catalog # Description Quantity Price (USD)
Plasmid 114103 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
  • Backbone size w/o insert (bp) 4552
  • Total vector size (bp) 6888
  • Vector type
    Mammalian Expression, AAV

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
  • Growth Strain(s)
    NEB Stable
  • Copy number
    Low Copy

Gene/Insert 1

  • Gene/Insert name
    Gaussia luciferase, slow burn
  • Alt name

Gene/Insert 2

  • Gene/Insert name
    Volvox Channelrhodopsin 1
  • Alt name

Gene/Insert 3

  • Gene/Insert name
    Enhanced Yellow Fluorescent Protein
  • Alt name

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pAAV-Hb9-LMO3 (sbGLuc-VChR1-EYFP) was a gift from Ute Hochgeschwender (Addgene plasmid # 114103 ; ; RRID:Addgene_114103)
  • For your References section:

    Restoring Function After Severe Spinal Cord Injury Through BioLuminescent-OptoGenetics. Petersen ED, Sharkey ED, Pal A, Shafau LO, Zenchak-Petersen J, Pena AJ, Aggarwal A, Prakash M, Hochgeschwender U. Front Neurol. 2022 Jan 20;12:792643. doi: 10.3389/fneur.2021.792643 10.3389/fneur.2021.792643 PubMed 35126293